ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANNETTE OKAI MD

Neurology

718

$729K

65
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$1016
Average prescription price

Avg: $218

HOWARD DERMAN M.D.

Neurology

718

$55.8K

97
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $218

CHRIS VICENTE M.D.

Neurology

717

$45.4K

121
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

51%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$63
Average prescription price

Avg: $218

LAWRENCE SCHAEFFER M.D.

Neurology

714

$600K

115
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 28%

$841
Average prescription price

Avg: $218

RICKEY REYNOLDS MD PHD

Neurology

708

$159K

155
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$224
Average prescription price

Avg: $218

JORGE MARTINEZ-PRIETO MD

Neurology

701

$168K

189
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$240
Average prescription price

Avg: $218

MICHAEL ZUFLACHT M.D.

Neurology

692

$266K

106
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$384
Average prescription price

Avg: $218

SIMON TAN MD

Neurology

690

$137K

99
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 28%

$199
Average prescription price

Avg: $218

KAREN FINK PH.D., M.D.

Neurology

688

$98.8K

52
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$144
Average prescription price

Avg: $218

HAZEM MACHKHAS MD

Neurology

688

$60K

118
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $218

EDWARD PAN MD

Neurology

686

$135K

80
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$196
Average prescription price

Avg: $218

DEVANSHI GUPTA M.D.

Neurology

685

$361K

112
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$527
Average prescription price

Avg: $218

MELISSA THOMAS M.D.

Neurology

674

$130K

85
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$193
Average prescription price

Avg: $218

JAMSHID LOTFI MD

Neurology

666

$54.6K

98
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

34%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $218

JOHN LINDSEY M.D.

Neurology

662

$947K

54
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 28%

$1431
Average prescription price

Avg: $218

JAMES FERRENDELLI M.D.

Neurology

660

$173K

86
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$263
Average prescription price

Avg: $218

CARLAYNE JACKSON M.D.

Neurology

656

$182K

86
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$277
Average prescription price

Avg: $218

OMOTOLA HOPE MD

Neurology

648

$146K

63
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$226
Average prescription price

Avg: $218

STEVEN LOVITT M.D.

Neurology

644

$112K

95
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$174
Average prescription price

Avg: $218

ANWARUL HAQ MD

Neurology

637

$30.3K

64
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $218

BRIAN LOFTUS M.D.

Neurology

635

$76.2K

51
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$120
Average prescription price

Avg: $218

JOEL WOLINSKY M.D.

Neurology

633

$127K

98
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 28%

$200
Average prescription price

Avg: $218

MARIA ALVAREZ M.D.

Neurology

633

$258K

105
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$407
Average prescription price

Avg: $218

ANJALI SHAH MD

Neurology

632

$562K

64
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 28%

$890
Average prescription price

Avg: $218

ELIZABETH SAMUEL MD

Neurology

626

$82.2K

97
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$131
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank